INTRODUCTION
============

Clathrin-coated vesicles mediate the transfer of membrane proteins between different cellular compartments. Heterotetrameric adaptor protein (AP) complexes bind short linear motifs on cargo proteins and incorporate them into forming vesicles by linking them to the clathrin coat ([@B16]). Five AP complexes (AP-1 to AP-5) have been identified that are believed to regulate distinct trafficking pathways at the Golgi, endosome/lysosome, or plasma membrane ([@B25]). These AP complexes share the same basic plan, being composed of two large subunits (β1-5 and γ/α/δ/ε/ζ, ∼100 kDa), one medium subunit (μ1-5, ∼50 kDa), and one small subunit (σ1-5, ∼20 kDa). Use of alternate subunits has the potential to further expand the diversity of AP complexes ([@B46]). For example, three AP-1 subunits (γ, μ1, and σ1) have isoforms encoded by different genes, and mutations in the three σ1 isoforms AP1S1, AP1S2, and AP1S3 cause different diseases: MEDNIK syndrome, X-linked mental retardation, and pustular psoriasis, respectively ([@B61]; [@B47]; [@B56]).

Different AP subunits are responsible for binding clathrin, cargo-sorting motifs, accessory factors, and membrane lipids ([@B16]). Sorting motifs that conform to the YXXΦ consensus (where Φ is a bulky, hydrophobic amino acid) bind a conserved pocket in the medium subunit, whereas dileucine-sorting motifs (D/E)XXXL(L/I) are recognized by the small and non-β large subunits ([@B9]; [@B62]). In the case of AP-1, Arf1 cooperates with cargo and phosphoinositides to mediate membrane recruitment. Arf1-GTP bridges two AP-1 complexes by binding the β and γ subunits ([@B53]), whereas the γ subunit of AP-1 binds phosphatidylinositol 4-phosphate at a site similar to that used by the AP-2 α subunit to bind phosphatidylinositol (4,5)-bisphosphate ([@B24]). Finally, clathrin and accessory factors interact with linker and appendage domains of the large subunits, respectively.

The extent to which the use of variant subunit isoforms alters adaptor function is not well understood. The ubiquitous AP-1A and epithelial cell--specific AP-1B complexes, which differ only in the incorporation of μ1A or μ1B, provide one of the best-studied examples ([@B5]; [@B48]). Several studies have suggested that differential lipid binding by the μ subunits directs AP-1A to the Golgi but causes AP-1B to localize to recycling endosomes, presenting a plausible basis for their functional diversity ([@B20]; [@B18]). However, subsequent work showed AP-1A and AP-1B largely colocalize and that μ1A and μ1B recognize cargo proteins with different affinities ([@B22]). Thus the basis for the differential functions of these isoforms is unclear ([@B54]), and it is not known whether subunit exchange alters the function of other adaptor complexes.

Of the three AP complexes in the yeast *Saccharomyces cerevisiae*, only AP-1 uses alternate subunits. The two forms of AP-1 share the same large (Apl2 and Apl4) and small (Aps1) subunits but incorporate different medium subunits (Apm1 or Apm2). Whereas the classical Apm1-containing AP-1 complex transports well-characterized cargo, including chitin synthase III (Chs3) and Sna2 ([@B63]; [@B52]), no function has been identified for the Apm2-containing complex, which we refer to as AP-1R (AP-1 *R*elated). Early studies suggested that these complexes are biochemically distinct ([@B60]; [@B64]). Whereas Apm1 and Apm2 were proposed to act redundantly in trafficking the lipid flippase Drs2 ([@B43]), Apm2 is dispensable for many clathrin-dependent sorting events ([@B60]).

Here we show that the Apm2 subunit confers distinct functions on the yeast AP-1 complex. AP-1R and AP-1 sort distinct cargo proteins and exhibit differential sensitivity to cationic lipophilic drugs. These differences are not readily explained by divergent cargo recognition properties because AP-1R is unable to substitute for AP-1 in the sorting of cargo via a dileucine-based motif that is recognized by subunits common to both AP-1 and AP-1R. Strikingly, Apm2 but not Apm1 binds a novel regulatory protein that we call Mil1 (*m*u-*i*nteracting *l*igand). Mil1 is a predicted serine hydrolase that is required for Apm2-dependent sorting processes and has a role in recruiting Apm2 to membranes. This suggests that binding of specific regulatory factors might be an important mechanism by which subunit exchange confers new functions on clathrin adaptors.

RESULTS
=======

Apm2 is part of a functionally distinct AP-1--related complex
-------------------------------------------------------------

Previously we uncovered genes required for the trafficking of the vesicle soluble *N*-ethylmaleimide--sensitive factor attachment protein receptor (v-SNARE) Snc1 in a genome-wide screen that assessed changes in the surface levels of the GFP-Snc1-Suc2 (GSS) reporter protein ([@B8]). Genetic and physical interaction analysis identified a cluster of four genes, representing three AP-1 subunits (Apm2, Apl4, and Aps1) and the uncharacterized Yfl034w, whose deletion increased surface GSS levels. The identification of Apm2, but not the more abundant μ-subunit isoform Apm1, was unexpected and suggested that Apm2-containing AP-1R complex has a specific role in Snc1 sorting. To confirm these observations, we used a quantitative assay that measures the invertase (Suc2) activity of GSS present at the cell surface ([Figure 1A](#F1){ref-type="fig"}; [@B13]). Loss of *APM2*, *APL4*, and *APS1* led to a slight but significant increase in GSS surface levels, comparable to that of the endocytosis mutant *yap1801* ([@B8]). This increase was not observed in the absence of *APM1*, showing that GSS sorting is an AP-1R--specific function and does not require the Apm1-containing AP-1 complex, which we will refer to here as AP-1.

![*APM1* and *APM2* deletions have distinct sorting phenotypes. (A) *APM2* but not *APM1* is required for Snc1 sorting. Cell-surface levels of the Snc1 reporter GSS were quantified in yeast deletion strains by measuring invertase activity of liquid cultures normalized to wild type. Unpaired *t* test of mutant strains compared with wild type, \*\*\**p* \< 0.0001 and \*\**p* \< 0.01. Error bars represent SEM (*n* = 6). (B) Deletion of *APM1* but not *APM2* bypasses the Chs3 trafficking defect of a *chs6* mutant strain. Chs3 surface activity was quantified as the fluorescence intensity of strains plated on 50 μg/ml calcofluor white and reported in arbitrary units (A.U.). Unpaired *t* test compared with wild type, \*\*\**p* \< 0.0001 and \**p* \< 0.05. Error bars represent SEM (*n* = 8). (C) To assess drug sensitivity, yeast were spotted in 10× dilution series and grown on YPD with Hyg B plus indicated drugs or DMSO as control.](588fig1){#F1}

Previous studies showed that the AP-1 complex is required for the transport of the chitin synthase Chs3 between Golgi and endosomal compartments ([@B63]). Exomer mutants, such as *chs6*, have low chitin levels because Chs3 is not transported to the surface but instead is retained in an AP-1--dependent intracellular recycling loop. Deletion of the large AP-1 subunit Apl2 or of Apm1 bypasses this intracellular retention, restoring Chs3 transport to the cell surface and chitin production. Previous studies found no role for Apm2 in Chs3 sorting using a qualitative assay ([@B63]). To detect subtle defects, we assessed the requirement for Apm2 in Chs3 transport using a sensitive quantitative assay based on the fluorescent compound calcofluor white (CW; [@B39]; [@B7]), which binds chitin produced by cell-surface Chs3. Whereas deletion of AP-1 components (*APM1*, *APL2*) restored wild-type cell surface levels of Chs3 in *chs6* cells, deletion of *APM2* or *YFL034W* did not ([Figure 1B](#F1){ref-type="fig"}). These results confirm that Apm2 does not play a role in the AP-1--mediated sorting of Chs3.

Because the Snc1 sorting defect in *apm2* mutants was relatively mild, we sought alternative phenotypes that distinguish Apm1 and Apm2. Genome-wide chemogenomic studies ([@B26]; [@B40]) suggested that Apm1 and Apm2 have differential drug sensitivities. By exposing *apm1* and *apm2* strains to a subset of these drugs, we found that strains lacking *APM1* but not *APM2* were sensitive to myriocin, an inhibitor of sphingolipid biosynthesis ([Figure 1C](#F1){ref-type="fig"}). In contrast, *apm2* mutants were sensitive to cationic amphiphilic drugs (CADs) such as sertraline, as previously reported ([@B51]), whereas *apm1* mutants exhibited sertraline resistance ([Figure 1C](#F1){ref-type="fig"}). CADs intercalate in phospholipid bilayers and may interfere with protein function, including lipid binding ([@B14]). The differential sensitivities of these adaptor protein mutants may reflect missorting of cargo and be important in responding to stresses imposed by the drug. These differential drug sensitivities, together with the cargo-specific sorting defects, demonstrate that Apm1 and Apm2 have distinct functions.

AP-1R localizes to the late Golgi and early endosomes
-----------------------------------------------------

Because Snc1 undergoes a rapid cycle of internalization and recycling to the plasma membrane, increased surface levels in cells lacking AP-1R could reflect reduced endocytosis or an enhanced rate of recycling from intracellular compartments. To determine whether Apm2 is part of the endocytosis machinery, we compared the localizations of Apm2-GFP and the AP-2 medium subunit Apm4-GFP with that of clathrin light chain Clc1-RFP in *sla2* strains, which stall endocytosis of clathrin-coated pits ([@B30]; [@B49]). Whereas Apm4-GFP colocalized with Clc1-RFP at the plasma membrane, Apm2-GFP was largely localized to intracellular clathrin compartments ([Figure 2A](#F2){ref-type="fig"}). A small number of Apm2-GFP puncta were observed at or near the plasma membrane. To determine whether these represent sites of endocytosis, we carried out time-lapse imaging using total internal reflection fluorescence microscopy of cells treated with the actin inhibitor latrunculin A (LatA) to block the budding of cell-surface clathrin-coated pits. The AP-2 subunit Apm4-GFP maintained strong colocalization with Clc1--red fluorescent protein (RFP) at immobile patches on the plasma membrane ([Figure 2B](#F2){ref-type="fig"}). In contrast, Apm2-GFP--containing structures near the cell surface were highly mobile and did not colocalize with plasma membrane Clc1-RFP puncta over time. Some lack of colocalization between AP-1 and clathrin was previously observed ([@B12]), suggesting that adaptors can be present at membranes without significant clathrin binding. The absence of AP-1R at the plasma membrane is inconsistent with a role in endocytosis and suggests instead that it functions in an intracellular pathway.

![Apm2 localizes to late Golgi/early endosomes. (A) Fluorescence microscopy of live endocytosis-defective *sla2* yeast shows that Apm2 is not present at cell-surface clathrin-coated pits. White arrows indicate puncta that colocalize in GFP and RFP channels. (B) Kymograph analysis of Apm4-GFP or Apm2-GFP relative to cortical clathrin patches marked by Clc1-RFP. Cells were incubated with the actin inhibitor latrunculin A and imaged by TIRF microscopy. (C) Localization of Apm2-GFP relative to that of Apm1-tdTomato (AP-1 complex), Anp1-RFP (early Golgi), Sec7-DsRed (late Golgi/endosomes), and Snf7-RFP (late endosomes). Scale bar, 4 μm.](588fig2){#F2}

To define the intracellular distribution of Apm2-GFP, we performed colocalization experiments with fluorescently tagged marker proteins (*n* = 3, \>125 cells/experiment; [Figure 2C](#F2){ref-type="fig"}). Consistent with a role in Golgi/endosomal sorting, 63 ± 3% of Apm2-GFP puncta colocalized with the late-Golgi/early endosome marker Sec7-dsRed. Apm2-GFP only partially colocalized with the early Golgi marker Anp1-RFP (28 ± 3%) and showed little colocalization with the late endosome marker Snf7-RFP (8 ± 1%). These results indicate that AP-1R localizes primarily to the late Golgi/early endosomes, similar to previous findings placing AP-1 at these compartments ([@B43]; [@B12]). Of importance, Apm2-GFP showed extensive colocalization with Apm1-tdTomato (77 ± 2%), suggesting that the bulk of AP-1R is present at the same intracellular compartment as AP-1.

Recognition of tyrosine-based signals by Apm1 and Apm2
------------------------------------------------------

The different phenotypes of *apm1* and *apm2* mutants suggest that Apm1 and Apm2 recognize different cargo for incorporation into vesicles. The μ subunits of AP complexes interact with tyrosine-based motifs (YxxΦ; [@B9]) via residues conserved in both Apm1 and Apm2 (Supplemental Figure S1A). The vacuolar protein Sna2 has two tyrosine-based sorting motifs at Y65 and Y75, which govern its trafficking by AP-1 and AP-3, respectively ([@B52]). We tested sorting of a Sna2 mutant (Sna2^Y75A^) that lacks the AP-3 signal and whose vacuolar transport depends on AP-1 ([Figure 3, A](#F3){ref-type="fig"} and [B](#F3){ref-type="fig"}). Loss of the AP-1 components Apl4 and Apm1 missorted Sna2^Y75A^-GFP to the cell surface, consistent with previous studies ([@B52]). The Sna2 tyrosine-based signal is expected to bind the conserved pocket in Apm1. Indeed, a version of Apm1 containing mutations at this site (APM1^tyr^: F179A D181S) was present at the same level as wild-type Apm1 (Supplemental Figure S1B) but was unable to rescue the Sna2^Y75A^-GFP sorting defect of an *apm1* mutant.

![The predicted YxxΦ-binding pocket is required for some but not all functions of Apm1 and Apm2. (A) Expression of an Apm1 mutant lacking a functional tyrosine signal-binding pocket (*apm1*^tyr^) or overexpression of *APM2* from the *APM1* promoter (*APM2*^OE^) is unable to restore the vacuolar localization of the AP-1--specific cargo Sna2^Y75A^-GFP in *apm1* mutant cells. Scale bar, 2 μm. (B) Quantification of surface fluorescence of Sna2^Y75A^-GFP. Error bars represent SEM (*n* = 3). Unpaired *t* test compared with *apm1Δ*, \*\*\**p* \< 0.0001 and \*\**p* \< 0.01. (C) An Apm2 mutant lacking a functional tyrosine signal-binding pocket (apm2^tyr^) and expressed on a plasmid from its native promoter exhibits sertraline sensitivity. Yeast were plated in a 10× dilution series on YPD containing Hyg B and DMSO or 22.5 μM sertraline. (D) The *apm2*^tyr^ mutant is unable to restore sorting of the Snc1 reporter GSS. Cell-surface GSS levels in the indicated strains were determined by quantifying invertase activity and normalizing to levels in wild-type cells. Unpaired *t* test compared with wild type, \*\*\**p* \< 0.0001. Error bars represent SEM (*n* = 6). (E) Wild-type *APM1* and *apm1*^tyr^, but not overexpressed *APM2* (*APM2*^OE^), restores the calcofluor resistance of *chs6 apm1* mutants. Yeast were plated in a 10× dilution series on buffered YPD containing Hyg B and 50 μg/ml calcofluor white (CW). (F) Representative fluorescence images of calcofluor white--stained strains.](588fig3){#F3}

We found that Apm2 is not required for Sna2^Y75A^-GFP sorting ([Figure 3, A](#F3){ref-type="fig"} and [B](#F3){ref-type="fig"}; [@B52]). However, it is much less abundant than Apm1 and could have a minor but redundant role that would not be detected in knockout experiments. To determine whether Apm2 can substitute for Apm1 when expressed at similar level, we placed hemagglutinin (HA)-tagged Apm2 under the Apm1 promoter (*APM2^OE^*). We confirmed that expression of Apm2 was comparable to that of Apm1 (Supplemental Figure S1) but observed no rescue of Sna2^Y75A^-GFP sorting in an *apm1* strain. In contrast, reintroduction of wild-type Apm1 significantly restored localization of Sna2^Y75A^-GFP to the cell surface (*n* = 3, *p* = 0.0005; [Figure 3B](#F3){ref-type="fig"}). These results suggest that whereas Apm1 sorts Sna2 through a tyrosine-based motif, Apm2 does not. Apm2 could lack a functional YxxΦ-binding pocket. However, wild-type Apm2, but not the Apm2 tyrosine motif-binding mutant (Apm2^tyr^: F273A D275S), rescued growth on sertraline in an *apm2* background ([Figure 3C](#F3){ref-type="fig"}), suggesting that Apm2 may sort a protein required for sertraline resistance via a tyrosine-containing signal. The Snc1 cytosolic domain lacks tyrosine residues and may bind to Apm2 via a noncanonical sorting motif. Of interest, the Apm2^tyr^ mutant also failed to sort GSS in the invertase assay ([Figure 3D](#F3){ref-type="fig"}). This suggests that Apm2 sorts another cargo necessary for the normal recycling of Snc1 or that a noncanonical signal in Snc1 binds the same site in Apm2.

AP-1 binds Chs3 via a dileucine-based motif ([@B59]). Such motifs are recognized by the γ/σ subunits. Thus mutation of the Apm1 tyrosine-binding pocket is not predicted to affect Chs3 sorting. To test this, we grew serial dilutions of deletion strains on media containing toxic amounts of calcofluor white ([Figure 3E](#F3){ref-type="fig"}). Exomer mutants, such as *chs6*, that retain Chs3 inside the cell have reduced chitin and are resistant to calcofluor white, whereas AP-1 mutants that bypass *chs6* and allow Chs3 to reach the surface restore calcofluor white sensitivity. Expression of either wild-type *APM1* or *apm1^tyr^* in the *chs6 apm1* background resulted in a *chs6* phenotype ([Figure 3, E](#F3){ref-type="fig"} and [F](#F3){ref-type="fig"}), confirming that Chs3 sorting does not require the Apm1 YxxΦ-binding pocket.

Because the dileucine-based motif of Chs3 binds the γ/σ subunits present in both AP-1 and AP-1R, Apm2 should substitute for Apm1 if present at the same level. Surprisingly, expression of *APM2* from the *APM1* promoter did not alter the calcofluor white*--*sensitive phenotype of *chs6 apm1* strains ([Figure 3, E and F](#F3){ref-type="fig"}), indicating that AP-1R is incapable of sorting Chs3. This result suggests that differential cargo recognition is not the reason for the different sorting specificity of AP-1 and AP-1R.

Mil1(Yfl034w) specifically binds the Apm2 C-terminal subdomain B
----------------------------------------------------------------

One explanation for the functional differences between Apm1 and Apm2 is that they bind different regulatory proteins that direct them into specific pathways. The uncharacterized protein Yfl034w clustered with AP-1R subunits in our genome-wide analysis ([@B8]) and, like Apm2, was required for sorting of the Snc1 reporter but not Chs3 ([Figure 1, A](#F1){ref-type="fig"} and B), suggesting that it shares a closely related function. On the basis of results described later, we refer to Yfl034w as Mil1 (*m*edium adaptin-*i*nteracting *l*igand).

Physical interactions between Mil1 and components of the AP-1 complex were reported in several proteomic studies ([@B21]; [@B35]; [@B10]; [@B1]). We confirmed this interaction, showing that Mil1-GFP copurifies with Apl4-HA immunoprecipitated from yeast cell lysates ([Figure 4A](#F4){ref-type="fig"}). Like all heterotetrameric clathrin adaptors, AP-1 consists of a core complex with two appendages ("ears") projecting from the large subunits by flexible linkers ([@B16]). Although the Apl4 (γ) appendage recruits many regulatory proteins, Mil1 was able to bind a truncated form of Apl4 lacking this appendage (Apl4Δear; [Figure 4A](#F4){ref-type="fig"}). We reasoned that if Mil1 is an AP-1R regulator, it might associate preferentially with Apm2, which is part of the core complex. Apm2-HA was present at low levels in the cell lysate, yet we observed a clear enrichment of Apm2-HA upon immunoprecipitation of Mil1-GFP, whereas there was little if any pull down of Apm1-HA, showing that the physical interaction between Apm2 and Mil1 is highly specific ([Figure 4B](#F4){ref-type="fig"}).

![Mil1 interacts with Apm2 through its WQEMP motif. (A) Mil1-GFP copurified with immunoprecipitated Apl4-3HA and with a truncated version lacking the γ appendage (Apl4Δear-HA) known to bind several AP-regulatory proteins. Loading of lysate relative to immunoprecipitate was 1:9. All proteins were genomically tagged. (B) Pull down of Mil1-GFP in strains coexpressing either Apm1-3HA or Apm2-3HA shows that Mil1 binds specifically to Apm2. All proteins were genomically tagged. (C) Phyre2 homology model of Apm2, colored to indicate the N-terminal AP-binding domain (green) and a C-terminal region composed of A (yellow) and B (magenta) subdomains. Key residues predicted to be involved in YxxΦ binding (red) or lipid binding (blue) based on alignment with regions of AP-1 and AP-2 μ subunits are indicated. (D) Yeast two-hybrid mapping of Apm2-Mil1--binding domains. Full-length or truncated Apm2 constructs were fused to the GAL4 DNA-binding domain (GBD), and full-length, truncated, or mutated Mil1 constructs were fused to the GAL4-activating domain (GAD). Qualitative interaction strengths are indicated. Mil1^WQEMP^ represents the W^143^QEMP\>AAEAA mutant, and Mil1^FNIY^ represents the F^152^NIY\>ANAA mutant. (E) Anti-GFP immunoprecipitation of plasmid-expressed wild-type Mil1-GFP or Mil1^WQEMP^-GFP from strains coexpressing genomically tagged Apm2-3HA. (F) Sertraline sensitivity was assessed by plating strains in a 10× dilution series on YPD containing 22.5 μM sertraline or DMSO as a control. (G) The *mil1^WQEMP^* mutant is unable to restore sorting of the Snc1 reporter GSS. Cell-surface GSS levels in the indicated strains were determined by quantifying invertase activity and normalizing to levels in wild-type cells. Unpaired *t* test compared with wild type, \*\*\**p* \< 0.0001 and \**p* \< 0.05. Error bars represent SEM (*n* = 10).](588fig4){#F4}

A yeast two-hybrid assay was used to map interacting regions. Based on structural homology to other μ adaptins, Apm2 has an N-terminal domain required for its incorporation into the AP complex, whereas the C-terminus consists of two subdomains: an A domain, containing the tyrosine-binding pocket, and a B domain, which may contribute to membrane recruitment but does not contain known cargo-binding sites ([Figure 4C](#F4){ref-type="fig"}; [@B18]; [@B9]). The minimal Mil1-binding region was mapped to residues 389--562, which correspond to the B domain ([Figure 4D](#F4){ref-type="fig"}).

Additional mutations were used to define the Apm2-binding site on Mil1. First, the interaction was narrowed to a region between residues 125 and 175. Point mutations that alter conserved residues in this 50--amino acid fragment revealed that a F^152^NIY\>ANAA mutant retained the yeast two-hybrid interaction with Apm2, but a W^143^QEMP\>AAEAA mutant did not. Furthermore, introducing the W^143^QEMP\>AAEAA mutation into the full-length Mil1 protein resulted in a Mil1^WQEMP^ mutant that was stably expressed but did not coprecipitate with Apm2 ([Figure 4E](#F4){ref-type="fig"}).

Having identified an Apm2 binding--deficient Mil1 mutant, we tested whether the Apm2-Mil1 interaction was important for Apm2 function. Sensitivity of *MIL1* deletion strains could be rescued by a plasmid expressing Mil1 or the full-length F^152^NIY\>ANAA (Mil1^FNIY^) mutant, whereas the Mil1^WQEMP^ mutant showed only weak complementation ([Figure 4F](#F4){ref-type="fig"}). In addition, only wild-type Mil1 was able to complement GSS sorting ([Figure 4G](#F4){ref-type="fig"}). Thus the Apm2-Mil1 interaction is functionally important, suggesting that Mil1 plays a key role in AP-1R--mediated sorting processes.

Mil1 has a conserved α/β-hydrolase catalytic motif required for its function
----------------------------------------------------------------------------

Mil1, which contains a C-terminal DUF726 domain, is predicted to be a serine hydrolase with an α/β hydrolase fold ([@B2]). Serine hydrolases constitute a large protein family that uses the conserved serine nucleophile to hydrolyze amide, ester, and thioester bonds in a variety of substrates ([@B41]). Alignment of Mil1 and its homologues revealed conserved residues that match the Ser-Asp-His catalytic triad of many serine hydrolases, consisting of S759 within a GxSxG motif, D817, and H858 ([Figure 5A](#F5){ref-type="fig"}). Structural modeling using Phyre2 ([@B31]) suggested the DUF726 domain of Mil1 is most similar to lipases and that residues S759, D817, and H858 are oriented in the necessary geometry to form a catalytic triad ([Figure 5B](#F5){ref-type="fig"}). The active site of the well-characterized lipase CalB from *Candida antarctica* is shown for comparison; CalB was one of the highest template matches used for three-dimensional (3D) homology modeling.

![Mil1 has a conserved serine hydrolase catalytic triad. (A) BLAST alignment of the conserved DUF726 domain in Mil1. Intensity of blue-highlighted residues corresponds to percentage identity. Conserved residues corresponding to the predicted Ser-Asp-His catalytic triad are highlighted in red. (B) Structural model showing the catalytic triad of the well-characterized lipase B from *C. antarctica* (left; Protein Data Bank ID: 1TCA) and the Phyre2 homology model showing the predicted catalytic triad of Mil1 (right). (C) Sertraline sensitivity was assessed by plating strains in a 10× dilution series on YPD containing 22.5 μM sertraline or DMSO as a control.](588fig5){#F5}

To investigate whether Mil1 is likely to have an enzymatic activity important for Apm2-dependent sorting pathways, we tested the sertraline resistance of mutants carrying an alanine substitution of each predicted catalytic residue. A plasmid expressing wild-type Mil1 fully complemented the sertraline sensitivity of a *mil1* strain, but the S759A (S\>A), D817A (D\>A), and H858A (H\>A) mutants were only partially functional ([Figure 5C](#F5){ref-type="fig"}), despite being expressed at similar levels (unpublished data). Each catalytic mutant displayed a similar level of sertraline sensitivity, suggesting that the putative catalytic activity of Mil1 contributes to Apm2 function.

Mil1 is a peripheral membrane protein that promotes Apm2 recruitment
--------------------------------------------------------------------

The transmembrane prediction algorithms Phobius ([@B38]) and TMHMM ([@B36]) suggest that Mil1 contains four transmembrane domains. However, two of these predicted TMDs overlap the DUF726 α/β hydrolase domain, which is expected to be soluble. Subcellular fractionation was used to examine Mil1 membrane association under conditions that can dislodge peripheral, but not integral, membrane proteins ([Figure 6A](#F6){ref-type="fig"}). In the presence of high salt concentrations, the transmembrane protein Pep12 was found in the pellet (P100) fraction as expected, whereas Mil1 was present exclusively in the soluble (S100) fraction, indicating that Mil1 is peripherally associated with membranes.

![Mil1 is a peripheral membrane protein that promotes Apm2 membrane recruitment. (A) Subcellular fractionation of Mil1 and the transmembrane protein Pep12. WCE, whole-cell extract. P13, low-speed pellet fraction; P100, high-speed pellet fraction; S100, high-speed soluble fraction. Samples were resolved by 15% SDS--PAGE and detected by immunoblotting. (B) Representative maximum-intensity *z*-projection images from nine slices at 0.3-μm increments. Scale bar, 2 μm. (C) Localization of Mil1-GFP in wild-type or *apm2* mutant strains quantified in a single slice. Unpaired *t* test, \**p* \< 0.05. Error bars represent SEM (*n* = 3). (D) Representative maximum-intensity *z*-projection images from nine slices at 0.3-μm increments. Scale bar, 2 μm. (E) Localization of Apm2-GFP expressed in wild-type or *mil1* mutant strains and quantified in a single slice. Unpaired *t* test, \*\*\**p* \< 0.0001, \*\**p* \< 0.01, and \**p* \< 0.05. Error bars represent SEM (*n* = 4). (F) Proposed model: Mil1 helps to recruit Apm2 to a distinct membrane region.](588fig6){#F6}

We hypothesized that binding of Mil1 to the B domain of Apm2 could be responsible for its membrane recruitment. Accordingly, we examined the localization of Mil1-GFP in wild-type and *apm2* mutants ([Figure 6B](#F6){ref-type="fig"}). We observed a slight but significant decrease in the number of Mil1-GFP puncta in *apm2* cells compared with wild type, which could be complemented by introduction of *APM2* on a plasmid ([Figure 6C](#F6){ref-type="fig"}). Thus Mil1 localization seems to be largely Apm2 independent.

We also considered the hypothesis that Mil1 promotes Apm2 membrane recruitment. We saw a significant decrease in the number of Apm2-GFP puncta in *mil1* cells compared with wild-type strains ([Figure 6D](#F6){ref-type="fig"}). Loss of Mil1 reduced the number of Apm2 puncta by ∼50% ([Figure 6E](#F6){ref-type="fig"}) but did not significantly change the number of Apm1-GFP or Sec7-dsRed puncta (Supplemental Figure S2, A and B). Of note, the Mil1^S\>A^ catalytic-site mutant complemented this defect almost as well as wild-type Mil1, but the Mil1^WQEMP^ deficient in Apm2 binding failed to complement, suggesting that direct physical interaction between Mil1 and Apm2, but not Mil1 catalytic activity, is important for recruitment of Apm2, but not Apm1, to membranes.

DISCUSSION
==========

Subunit exchange may represent a general mechanism for creating functionally distinct adaptor complexes. How the incorporation of distinct but highly homologous μ subunits alters the function of the two AP-1 complexes of mammalian epithelial cells, AP-1A and AP-1B, is the subject of debate ([@B54]). Although AP-1A and AP-1B were shown to localize to different intracellular compartments in early studies, recent work suggested that these adaptor complexes are present in the same vesicles but recognize different cargo ([@B22]). Our work provides an example of how subunit exchange can create functionally distinct AP-1 adaptor complexes in yeast and highlights the importance of unique interactions with regulatory partners in this process.

We find that inclusion of either Apm1 or Apm2 changes the cargo specificity of AP-1 complexes: whereas the classical Apm1-containing AP-1 complex is involved in sorting Chs3 and Sna2, consistent with previous studies ([@B63]; [@B52]), the Apm2-containing AP-1R complex works in pathways that sort the v-SNARE Snc1 and give resistance to sertraline. The lipid flippase Drs2 is the only cargo reported to require both Apm1 and Apm2 for its localization ([@B43]). Because Drs2 regulates the formation of AP-1/clathrin-coated vesicles by generating membrane curvature, it may constitute an essential component of vesicles in both AP-1-- and AP-1R--dependent pathways.

We showed that Apm2 could not substitute for Apm1 in Sna2 or Chs3 sorting even when expressed at similar levels, suggesting that these μ adaptins share little functional overlap. Some of these differences could result from differential cargo binding. The μ adaptins of AP-1, AP-2, and AP-3 bind YxxΦ motifs at a conserved site ([@B50]; [@B29]; [@B45]). We found that mutations in Apm1 that disrupt this site block the YxxΦ-dependent AP-1 sorting of Sna2, whereas corresponding mutations in Apm2 cause sertraline sensitivity, suggesting that resistance to this drug requires correct sorting of a YxxΦ-containing cargo by Apm2. Thus, whereas both Apm1 and Apm2 are likely to recognize YxxΦ motifs, small variations at this site could alter the affinity for different cargo, as reported for AP-1 and AP-3 ([@B45]).

Apm1 and Apm2 may have additional sites for binding noncanonical signals, as demonstrated for AP-4 ([@B4]; [@B6]). Apm1 binds the Ste13 cytoplasmic via an 11--amino acid peptide that lacks recognized motifs ([@B19]). Snc1 also lacks consensus YxxΦ or dileucine sorting signals, suggesting that Apm2 recognizes a divergent sorting signal in the Snc1 cytoplasmic domain or acts indirectly to sort a protein that is itself needed for Snc1 transport. Further work will be needed to define the relative affinities of Apm1 and Apm2 for different sorting signals and determine whether the signals are bound at distinct sites on the μ chain.

Although differential recognition of sorting signals might explain some *apm1* and *apm2* phenotypes, Chs3 sorting, which depends solely on Apm1, requires a dileucine motif ([@B59]). Such motifs are typically recognized by the γ/σ subunits present in both AP-1 and AP-1R ([@B15]; [@B32]; [@B46]). Indeed, we found the Apm1 tyrosine-binding pocket required for Sna2 transport was dispensable for Chs3 sorting. The fact that Apm2 is unable to substitute for Apm1 in this pathway, even at comparable levels of expression, suggests that something other than cargo binding affinity distinguishes the AP-1 and AP-1R complexes. It is possible that the Chs3 dileucine signal binds noncanonically to the AP-1 μ subunit or that Apm2 alters the conformation or accessibility of a dileucine-binding site in the γ/σ subunits. However, we favor an alternative model: that AP-1R is located in a separate compartment or microdomain, where it does not encounter Chs3 ([Figure 6F](#F6){ref-type="fig"}). Although we found that Apm2 and Apm1 are largely present at the same Golgi/endosomal structures, our data are consistent with the model that AP-1 and AP-1R sort cargo into separate vesicle populations.

We identified an Apm2-interacting protein, Mil1, which was required specifically for Apm2-mediated protein trafficking. We hypothesize that Mil1 plays a key role in recruiting Apm2 into a distinct pathway in which Apm1 does not participate. Mil1 is predicted to be structurally similar to fungal lipases and phospholipases and contains conserved residues that match a Ser-Asp-His catalytic triad and GxSxG motif ([@B23]). Phospholipases A1 and A2 (PLA~1~ and PLA~2~) have been implicated in vesicle formation at the Golgi, either by producing cone-shaped lipids that promote membrane curvature or by creating particular phospholipid species that recruit trafficking components ([@B3]; [@B23]). The cytosolic phosphatidic acid phospholipase A1 (PAPLA1) is important in the COPII-dependent transport of rhodopsin 1 in flies, but this function does not require its active site GxSxG residues ([@B37]). Similarly, the lipid-binding activity of the phospholipase A1 family member p125A, but not its enzymatic activity, is suggested to maintain COPII residency at endoplasmic reticulum exit sites ([@B33]). We found that Mil1 mediates the efficient recruitment of Apm2 to membranes, and this requires Mil1-Apm2 interaction but not Mil1's presumed enzymatic activity. Because Mil1 is largely targeted to membranes in the absence of Apm2, it could bind a particular class of lipid and reinforce the recruitment of Apm2 to a specific microdomain, similar to the role proposed for p125A in COPII recruitment ([Figure 6F](#F6){ref-type="fig"}).

We found that a conserved sequence in a predicted flexible, extended N-terminal region of Mil1 interacted with the B lobe of the Apm2 medium chain, distal to known cargo-recognition sites. Thus Mil1 binding is unlikely to interfere with cargo recognition by Apm2, consistent with a regulatory role for Mil1. Of interest, other lipid-modifying proteins have been found to associate with AP μ subunits. AP-1 μ1B binds and activates the phosphatidylinositol 4-phosphate (PI(4)P) 5-kinase PIPKIγ, which may contribute to the formation of a phosphatidylinositol (3,4,5)-trisphosphate--enriched domain that favors further AP-1B recruitment ([@B42]; [@B18]). All three (PI(4)P) 5-kinase isoforms bind the C-terminal domain of AP2 μ subunit, and this does not require the AP2 μ subunit's tyrosine-binding pocket ([@B34]). We found that predicted active-site residues in Mil1 were not required for Apm2 recruitment but were partially required for Apm2-mediated processes, suggesting that Mil1 has a catalytic activity whose role is downstream of adaptor recruitment. Our discovery that Mil1 regulates vesicle trafficking in yeast indicates that its uncharacterized human homologue, TMCO4, may act in a similar process. The Apm2-binding region of Mil1 is not conserved in TMCO4, suggesting that this protein regulates other trafficking pathways in higher organisms. Further studies are required to determine the extent to which lipid-modifying proteins interact with different adaptor protein complexes and other coat proteins to regulate vesicle transport.

MATERIALS AND METHODS
=====================

Yeast strains and plasmids
--------------------------

All strains from this study were made by homologous recombination as described ([@B44]; [@B27]; [@B57]). BY4741 and BY4742 yeast strains were purchased from GE Dharmacon (Lafayette, CO). Strains were propagated in rich medium (YPD: 1% yeast extract, 2% peptone, 2% dextrose) or SD minimal medium (0.17% yeast nitrogen base, 0.5% ammonium sulfate, 2% synthetic complete mix, 2% dextrose) supplemented with the appropriate amino acids for plasmid selection. Plasmids were made by homologous recombination in yeast, rescued in *Escherichia coli*, and confirmed by sequencing. pHPH was made by PCR amplification of the hygromycin resistance gene HPH from pFA6a-hphNT1 and cotransformation of the PCR product with linearized pRS416. Proteins were tagged with either the bright GFP variant GFP+ ([@B55]) or GFP(envy) ([@B58]), a gift from C. Slubowski (University of Massachusetts, Boston, MA), by PCR amplification of the GFP::HIS cassette and transformation into yeast. Strains and plasmids are described in Supplemental Tables S1 and S2.

Chemical compounds
------------------

A calcofluor white (fluorescent brightener 28; Sigma Aldrich, St. Louis, MO) stock solution was made in 0.5 M Tris-HCl, pH 9.6, to a final concentration of 10 mg/ml. Stock solutions of sertraline hydrochloride (Cedarlane Laboratories, Burlington, Canada) and myriocin (Cayman Chemical Company, Ann Arbor, MI) of 25 and 1 mg/ml, respectively, were made in dimethyl sulfoxide (DMSO) and stored at −20°C until use. Myriocin was purchased from the Cayman Chemical Company, resuspended to a final concentration of 1 mg/ml in DMSO, and treated similarly. Hygromycin B (Hyg B; Roche Diagnostics, Indianapolis, IN) was purchased as a 50 mg/ml stock in phosphate-buffered saline. All other chemicals were purchased from Sigma-Aldrich and stored according to supplier's recommendations.

Invertase assay
---------------

Strains expressing the GSS construct were grown for 20 h in 2 ml of YP-fructose (final OD~600~ of ∼10). Cultures were diluted to 3 OD~600~/ml, and the liquid invertase assay was performed as described ([@B13]). Results are reported as nanomoles of glucose produced per 1 OD~600~ of culture, normalized to wild-type readings from the day. Glucose standards (ranging from 5 to 50 nM) and blanks were included in each experiment to ensure that measurements were within the linear range.

Calcofluor white assay
----------------------

The calcofluor assay was performed as described ([@B7]). Briefly, knockout strains were plated in 1536-array format onto YPD plates containing 50 μg/ml calcofluor white, using a Virtek automated colony arrayer (Bio-Rad Laboratories, Hercules, CA). After incubation at 30°C for 3 d, white-light images were acquired using a model 2400 flat-bed scanner (Epson, Nagano, Japan), and fluorescent-light images were captured with a Fluor S Max MultiImager (Bio-Rad Laboratories) using the 530DF60 filter and Quantity One software (version 4.2.1; Bio-Rad Laboratories). The open-source spot-finding program GridGrinder was used for densitometry of digital images.

Small-molecule inhibitor assays
-------------------------------

We spotted 1 OD~600~/ml of log-phase yeast grown under selective conditions to maintain plasmids (either SD-Leu or YPD + Hyg B) in 10× serial dilution on selective plates containing inhibitors or DMSO as a control, incubated them at 30°C for 3 d, and imaged them with a Canon Rebel T3I camera (Canon, Tokyo, Japan).

Fluorescence microscopy
-----------------------

Log-phase yeast in minimal selective media were imaged at room temperature with an Axioplan 2 fluorescence microscope (Carl Zeiss, Jena, Germany) equipped with a Plan-Apochromat 100×/1.40 numerical aperture (NA) oil immersion objective lens (Zeiss) and a CoolSNAP camera (Roper Scientific, Tucson, AZ) using MetaMorph 7.7 software (MDS Analytical Technologies, Sunnyvale, CA). Alternatively, in [Figures 2C](#F2){ref-type="fig"} and [6](#F6){ref-type="fig"}, images were acquired with a DMi8 microscope (Leica Microsystems, Wetzlar, Germany) using an HC PL APO 63×/1.30 Glyc CORR CS or an HC PL APO 100×/1.40 OIL STED WHITE objective (Leica) and an ORCA-Flash4.0 digital camera (Hamamatsu Photonics, Hamamatsu City, Japan). Images were adjusted using MetaMorph and Photoshop CS5 (Adobe, San Jose, CA). Maximum-intensity *z*-projections were based on *z*-stacks of nine planes with a 0.3-μm step size and made using MetaMorph after photobleaching correction based on histogram matching in Fiji ([www.fiji.sc/Fiji](http://www.fiji.sc/Fiji)). Cellular features were quantified by manually scoring images, except the Sec7-dsRed quantification, which was done by automated counting using in-house MetaMorph-based algorithms. For total internal reflection fluorescence (TIRF) microscopy experiments, cells from early log-phase cultures were incubated in a final concentration of 200 μM LatA dissolved in DMSO for 30 min at 30°C. We spotted 200 μl of treated cells onto concanavalin A--coated eight-well Lab-Tek dishes (Nalge Nunc International, Rochester, NY) and collected TIRF images with a 3i Marianas microscope (Intelligent Imaging Innovations, Denver, CO) equipped with an α-Plan-Fluor 100× 1.45 NA objective lens and a Zeiss TIRF slider (Carl Zeiss). Images were acquired with 488-nm and/or 561-nm laser excitation, with GFP and RFP emission split between two Cascade II 512 EM cameras (Photometrics, Tucson, AZ) with an Optical Insights Dual Cam (Photometrics) with an exposure time of 750 ms. TetraSpeck 100-nm beads (Life Technologies, Carlsbad, CA) were used to align the two channels and for subsequent registration in software. Slide-Book 4.2 software (Intelligent Imaging Innovations) was used for image acquisition and dual-channel image registration. Montages were created using ImageJ (National Institutes of Health, Bethesda, MD) with the Kymograph plug-ins installed ([www.embl.de/eamnet/html/kymograph.html](http://www.embl.de/eamnet/html/kymograph.html)).

Coimmunoprecipitation and Western blotting
------------------------------------------

Log-phase cells in YPD medium were converted into spheroplasts by digesting with Zymolyase (MJS BioLynx, Brockville, Canada), and stored at −85°C until use, as described ([@B11]). We resuspended 40 OD~600~ of cells in coimmunoprecipitation lysis buffer (20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, pH 7.5, 100 mM NaCl, and 2 mM EDTA, with 1% 3-\[(3-cholamidopropyl) dimethylammonio\]-2-hydroxy-1-propanesulfonate and 1 mM phenylmethylsulfonyl fluoride added before use) and centrifuged them for 15 min at 4°C. Supernatant fractions were incubated at 4°C for 1 h with rabbit anti-HA (Santa Cruz Biotechnology, Dallas, TX) or rabbit anti-GFP (Molecular Probes, Carlsbad, CA), followed by protein A--Sepharose beads (GE Healthcare, Little Chalfont, United Kingdom) for 2.5 h. The beads were washed, and proteins were eluted by heating at 95°C for 5 min. Samples were run on 10% SDS--PAGE gels. Proteins were transferred overnight to nitrocellulose membranes and blotted with either mouse anti-GFP (Roche) or mouse anti-HA (Covance, Princeton, NJ) and then with goat anti-mouse antibodies conjugated to horseradish peroxidase (Jackson ImmunoResearch, West Grove, PA). Blots were developed with the enhanced chemiluminescent West Pico (Pierce, Rockford, IL) and West Femto (Pierce) and exposed to Amersham Hyperfilm (GE Healthcare).

Yeast two-hybrid assay
----------------------

PJ694a strains carrying pGBDU-C2-based plasmids were mated to PJ694α strains carrying pGAD-C2-based plasmids, each expressing the indicated full-length or truncation proteins ([@B27]). Positive two-hybrid interactions were scored on minimal medium (SD-Ura-Leu-His+Ade) containing 3, 5, or 10 mM 3-amino-1,2,4-triazole.

Bioinformatic analyses
----------------------

All sequences are from Uniprot ([www.uniprot.org](http://www.uniprot.org)). Homologues in other organisms were found using the Panther classification system ([www.pantherdb.org](http://www.pantherdb.org)). Visualization of MUSCLE-aligned sequences ([@B17]) used Jalview ([www.jalview.org](http://www.jalview.org)). For 3D structure modeling, Phyre2 with "intensive" settings was used ([@B31]). Apm2 tyrosine-motif recognition pocket residues were labeled based on sequence conservation with known tyrosine-pocket residues of AP complex μ subunits ([@B50]; [@B24]), and the predicted region involved in lipid binding was extrapolated based on alignment with human μ1B ([@B18]).

Membrane fractionation
----------------------

The membrane fractionation protocol was adapted from [@B11]. Log-phase cells at 60 OD~600~ were spheroplasted, lysed, and spun at 500 × *g* for 5 min at 4°C. The P13 fraction was pelleted at 13,000 × *g* for 10 min at 4°C and resuspended in SDS sample buffer (5% SDS, 50 mM Tris, pH 6.8, 0.4 mg/ml bromophenol blue, 1% β-mercaptoethanol). The supernatant was centrifuged at 100,000 × *g* in a table-top ultracentrifuge for 60 min to generate the P100 pellet, which was resuspended in 1 ml of lysis buffer as the P100 fraction, and the supernatant was kept as the S100 fraction. For high-salt treatment of the P100 and S100 fractions, NaCl was added to a final concentration of 1 M before the 100,000 × *g* spin. Samples were trichloroacetic acid precipitated, resuspended in SDS sample buffer, and subjected to SDS--PAGE and immunoblotting.
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:   adaptor protein
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:   green fluorescent protein
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:   GFP:Snc1:Suc2 reporter

HA
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Hyg B

:   hygromycin B.
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